Kinderhook Industries chief Matt Bubis outlined plans to merge Enhabit’s hospice units into a single, scalable operation. The move signals the firm’s intent to deepen its footprint in home‑care services amid rising demand for end‑of‑life support. Enhabit’s assets will be consolidated under a unified brand, positioning Kinderhook for future growth in the coming years.

The company completed a $1.1 billion take‑private transaction, buying out public shareholders and placing Enhabit under private ownership. The deal, valued at roughly $100 million per share, gives Kinderhook the flexibility to streamline operations and invest in technology without market scrutiny. It also signals confidence from investors in the hospice sector’s resilience.

Private‑equity funds AEA, Bridgepoint and Kohlberg have turned their attention to oncology, citing a surge in cancer diagnoses and a shortage of specialized care providers. These firms are reportedly scouting for acquisitions that can deliver scalable services across diagnostics, treatments and patient support. Their interest underscores a broader shift toward integrated health solutions for patient care innovation across the healthcare sector.

For investors, Kinderhook’s consolidation and the oncology focus signal a broader trend of PE firms targeting high‑growth, essential‑services markets. The $1.1 billion deal demonstrates that hospice care can command premium valuations, while oncology acquisitions hint at a lucrative upside for firms willing to build end‑to‑end care ecosystems. This pattern may reshape asset allocation in health‑care funds.